Compare ADMA & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ADMA | RNST |
|---|---|---|
| Founded | 2004 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.5B |
| IPO Year | 2012 | 1994 |
| Metric | ADMA | RNST |
|---|---|---|
| Price | $16.31 | $35.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $32.00 | ★ $42.25 |
| AVG Volume (30 Days) | ★ 3.1M | 636.3K |
| Earning Date | 05-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.60 | ★ 2.07 |
| Revenue | ★ $42,219,783.00 | N/A |
| Revenue This Year | $27.46 | $31.83 |
| Revenue Next Year | $21.11 | $4.58 |
| P/E Ratio | $26.37 | ★ $17.03 |
| Revenue Growth | ★ 43.85 | N/A |
| 52 Week Low | $13.76 | $27.26 |
| 52 Week High | $25.67 | $42.11 |
| Indicator | ADMA | RNST |
|---|---|---|
| Relative Strength Index (RSI) | 53.14 | 31.94 |
| Support Level | $15.35 | $33.68 |
| Resistance Level | $17.53 | $35.73 |
| Average True Range (ATR) | 0.82 | 1.17 |
| MACD | 0.08 | -0.37 |
| Stochastic Oscillator | 68.97 | 5.66 |
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.